Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases
Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases
Active, not recruiting · NCT06777433 · Registry updated 2026-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases | Neoplasms by Site, brain disorder, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder | Active, not recruiting | Phase 2 | 2026-08-12 | NCT06777433 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medpace, Inc. | 17 |
| Radiopharm Theranostics, Ltd | 7 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ascension Illinois Oncology Research | Hoffman Estates | United States | 1 |
| BAMF Health | Grand Rapids | United States | 15 |
| Goshen Center for Cancer Care | Goshen | United States | 47 |
| Karmanos Cancer Institute | Detroit | United States | 153 |
| University of Michigan | Ann Arbor | United States | 538 |